PACS vs ENSG vs NHC vs CCRN vs ADUS

For growth investors, PACS Group, Inc.

(PACS) is the stronger pick with 29. 3% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). Addus HomeCare Corporation (ADUS) offers the better valuation at 18. 7x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate PACS Group, Inc. (PACS) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Addus HomeCare Corporation (ADUS) is the cheapest at 18.

7x versus The Ensign Group, Inc. at 29. 8x. On forward P/E, Addus HomeCare Corporation is actually cheaper at 14. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Addus HomeCare Corporation wins at 0. 70x versus The Ensign Group, Inc. 's 1. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, National HealthCare Corporation (NHC) delivered a total return of +162.

1%, compared to -22. 5% for Cross Country Healthcare, Inc. (CCRN). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus CCRN's -10. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Ensign Group, Inc.

(ENSG) is the lower-risk stock at 0. 42β versus Cross Country Healthcare, Inc. 's 0. 78β — meaning CCRN is approximately 85% more volatile than ENSG relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 3% for PACS Group, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), PACS Group, Inc.

(PACS) is pulling ahead at 29. 3% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: PACS Group, Inc. grew EPS 221. 1% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

National HealthCare Corporation (NHC) is the more profitable company, earning 8.

2% net margin versus -9. 0% for Cross Country Healthcare, Inc. — meaning it keeps 8. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADUS leads at 9. 7% versus -0. 3% for CCRN. At the gross margin level — before operating expenses — NHC leads at 37. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Addus HomeCare Corporation (ADUS) is the more undervalued stock at a PEG of 0. 70x versus The Ensign Group, Inc. 's 1. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Addus HomeCare Corporation (ADUS) trades at 14. 1x forward P/E versus 133. 8x for Cross Country Healthcare, Inc. — 119. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PACS: 32. 9% to $44. 67.

In this comparison, NHC (1.

4% yield), ENSG (0. 1% yield) pay a dividend. PACS, CCRN, ADUS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, The Ensign Group, Inc.

(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +752. 0% 10Y return). Both have compounded well over 10 years (ENSG: +752. 0%, CCRN: -10. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PACS (Financial Services) and ENSG (Healthcare) and NHC (Healthcare) and CCRN (Healthcare) and ADUS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PACS is a small-cap high-growth stock; ENSG is a mid-cap high-growth stock; NHC is a small-cap quality compounder stock; CCRN is a small-cap quality compounder stock; ADUS is a small-cap high-growth stock. NHC pays a dividend while PACS, ENSG, CCRN, ADUS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.